rs13181, KLC3;ERCC2

N. diseases: 134
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Carcinoma, Basal Cell
CUI: C4721806
Disease: Carcinoma, Basal Cell
91 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.030 0.667 3 1999 2005
Experimental Organism Basal Cell Carcinoma
63 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.030 0.667 3 1999 2005
Xeroderma Pigmentosum, Complementation Group D
111 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.938 32 2001 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.909 11 2002 2015
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.090 0.889 9 2002 2015
Squamous cell carcinoma of esophagus
329 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.040 1.000 4 2002 2012
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
1204 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.800 0.963 27 2003 2019
Malignant neoplasm of lung
CUI: C0242379
Disease: Malignant neoplasm of lung
1142 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.962 26 2003 2019
Primary malignant neoplasm of lung
CUI: C1306460
Disease: Primary malignant neoplasm of lung
981 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.962 26 2003 2019
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
2793 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.842 19 2004 2019
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
3417 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.842 19 2004 2019
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
1082 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.070 0.857 7 2004 2017
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
1168 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.070 0.857 7 2004 2017
Congenital chromosomal disease
CUI: C0008626
Disease: Congenital chromosomal disease
47 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.030 1.000 3 2004 2012
Skin carcinoma
CUI: C0699893
Disease: Skin carcinoma
24 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.030 0.667 3 2004 2014
Colorectal Carcinoma
CUI: C0009402
Disease: Colorectal Carcinoma
1962 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 0.800 15 2005 2019
Glioma
CUI: C0017638
Disease: Glioma
353 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.100 1.000 11 2005 2017
Malignant neoplasm of colon and/or rectum
502 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.080 0.750 8 2005 2016
melanoma
CUI: C0025202
Disease: melanoma
515 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.080 0.875 8 2005 2018
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.080 0.875 8 2005 2017
Adenocarcinoma Of Esophagus
CUI: C0279628
Disease: Adenocarcinoma Of Esophagus
81 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.030 1.000 3 2005 2008
Malignant neoplasm of skin
CUI: C0007114
Disease: Malignant neoplasm of skin
38 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.020 0.500 2 2005 2014
Squamous cell carcinoma
CUI: C0007137
Disease: Squamous cell carcinoma
257 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.020 1.000 2 2005 2009
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
82 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.020 1.000 2 2005 2018
Adenomatous Polyps
CUI: C0206677
Disease: Adenomatous Polyps
20 0.487 0.760 19 45351661 stop gained T/A;G snv 4.0E-06; 0.32 0.010 1.000 1 2005 2005